StonvexLoading…
StonvexCore line items from MAN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $17.96B | $17.85B | $18.91B | $19.83B |
Operating Income | $150.10M | $306.00M | $255.80M | $581.70M |
Net Income | $-13.30M | $145.10M | $88.80M | $373.80M |
EPS (Diluted) | $-0.29 | $3.01 | $1.76 | $7.08 |
Total Assets | $9.16B | $8.20B | $8.83B | $9.13B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $871.00M | $509.40M | $581.30M | $639.00M |
Free Cash Flow OCF − CapEx | $-161.40M | $258.10M | $270.00M | $347.70M |
Shares Outstanding | 46.60M | 48.30M | 50.40M | 52.80M |